Showing results (161-170 of 237) with videos related to

Sort By:
Pageof 24
European Journal of Heart Failure|June 27, 2024
Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant-level pooled analysis from the CANVAS Program and CREDENCE trialMuthiah Vaduganathan, Christopher P Cannon, Meg J Jardine, et al.
Circulation|June 27, 2018
Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney FunctionBrendon L Neuen, Toshiaki Ohkuma, Bruce Neal, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 31, 2023
Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR: A Post Hoc Analysis of the CREDENCE TrialSjoukje van der Hoek, Niels Jongs, Megumi Oshima, et al.
International Journal of Cardiology|June 23, 2020
The effects of combination canagliflozin and glucagon-like peptide-1 receptor agonist therapy on intermediate markers of cardiovascular risk in the CANVAS programClare Arnott, Brendon L Neuen, Hiddo J L Heerspink, et al.
The Lancet. Diabetes & Endocrinology|October 16, 2020
Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trialMegumi Oshima, Brendon L Neuen, Meg J Jardine, et al.
Kidney International Supplements|January 25, 2019
Action plan for optimizing the design of clinical trials in chronic kidney diseaseVlado Perkovic, Jonathan C Craig, Worawon Chailimpamontree, et al.
Environmental Toxicology and Chemistry|August 28, 2001
An interlaboratory study on the use of steroid hormones in examining endocrine disruptionM E McMaster, J J Jardine, G T Ankley, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 14, 2025
SGLT2 Inhibition and Hospitalizations in Patients with CKD: A Meta-Analysis of Kidney Outcome TrialsMegumi Oshima, Luke Buizen, Niels Jongs, et al.
Kidney International Supplements|January 25, 2019
Closing the gap between evidence and practice in chronic kidney diseaseMeg J Jardine, Bertram Kasiske, Dwomoa Adu, et al.
Diabetes, Obesity & Metabolism|September 21, 2020
Sodium-glucose co-transporter-2 inhibition and ocular outcomes in patients with type 2 diabetes: A systematic review and meta-analysisChao Li, Zien Zhou, Brendon L Neuen, et al.
Pageof 24